Treatment of <i>Candida glabrata</i> Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
ABSTRACT While Candida albicans remains the most common Candida isolate, Candida glabrata accounts for approximately 15 to 20% of all Candida infections in the United States. In this study we used immunosuppressed mice infected with C. glabrata to investigate the efficacy of liposomal amphotericin B...
Sábháilte in:
Príomhchruthaitheoirí: | Jon Olson, Jill Adler‐Moore, Peter J. Smith, Richard T. Proffitt |
---|---|
Formáid: | Artigo |
Teanga: | Béarla |
Foilsithe / Cruthaithe: |
2005
|
Rochtain ar líne: | https://doi.org/10.1128/aac.49.12.4895-4902.2005 |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
de réir: Olson, Jon A., et al.
Foilsithe / Cruthaithe: (2005) -
Caspofungin in Combination with Amphotericin B against Candida glabrata
de réir: Barchiesi, Francesco, et al.
Foilsithe / Cruthaithe: (2005) -
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
de réir: Cantón, Emilia, et al.
Foilsithe / Cruthaithe: (2006) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
de réir: Yamada, Shoko Merrit, et al.
Foilsithe / Cruthaithe: (2016) -
Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
de réir: Healey, Kelley R., et al.
Foilsithe / Cruthaithe: (2011)